CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 2,178,000	$ 2,030,000
Accounts receivable	0	346,000
Investment in sales-type sublease - current	0	532,000
Other current assets	65,000	99,000
Total current assets	2,243,000	3,007,000
Other assets:
Due from related parties	930,000	912,000
Investments in unconsolidated entities	141,000	160,000
Goodwill	315,000	0
Total other assets	1,386,000	1,072,000
Property and equipment:
Operating lease right-of-use asset	59,000	94,000
Total property and equipment	59,000	94,000
TOTAL ASSETS	3,688,000	4,173,000
Current liabilities:
Obligations under finance lease - current portion	0	89,000
Operating lease right-of-use liability - current portion	43,000	40,000
Accounts payable and accrued expenses	170,000	170,000
Income taxes payable	114,000	111,000
Total current liabilities	327,000	410,000
Operating lease right-of-use liability - net of current portion	23,000	66,000
Guarantee liability	11,000	11,000
Total liabilities	361,000	487,000
EQUITY
Common stock - par value $.01; 25,000,000 shares authorized; 7,792,185 shares issued and outstanding at December 31, 2021 and 2020	78,000	78,000
Additional paid-in capital	2,871,000	3,100,000
(Accumulated deficit) retained earnings	(119,000)	508,000
U.S. Neurosurgical Holdings, Inc. stockholders' equity	2,830,000	3,686,000
Noncontrolling interests	497,000	0
Total equity	3,327,000	3,686,000
TOTAL LIABILITIES AND EQUITY	$ 3,688,000	$ 4,173,000